{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:03:00Z","timestamp":1775322180135,"version":"3.50.1"},"reference-count":46,"publisher":"Japan Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0554","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T22:15:58Z","timestamp":1739484958000},"page":"525-533","source":"Crossref","is-referenced-by-count":2,"title":["Arterial stiffness, high fasting glucose, and fatty liver as risk factors for visceral obesity in middle-aged Chinese individuals: a cross-sectional study"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4166-9493","authenticated-orcid":false,"given":"Hajime","family":"Nawata","sequence":"first","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"},{"name":"Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka 812-8582, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ou","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglan","family":"Song","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Ito","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Obo","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Iwami","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyang","family":"He","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8707-6654","authenticated-orcid":false,"given":"Ken","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Zhichengheai Health Management Center, Leading Center, Tianfu Chengdu 610000, China"},{"name":"SKK Co Ltd, Tokyo 107-0062, Japan"},{"name":"Department of Surgery, Tokyo Women\u2019s Medical University, Tokyo 162-0054, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Pan XF, Wang L, Pan A (2021) Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 9: 373\u2013392.","DOI":"10.1016\/S2213-8587(21)00045-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Pouliot MC, Despr\u00e9s JP, Lemieux S, Moorjani S, Bouchard C, et al. (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73: 460\u2013468.","DOI":"10.1016\/0002-9149(94)90676-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, et al. (2013) Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 62: 921\u2013925.","DOI":"10.1016\/j.jacc.2013.06.027"},{"key":"4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12889-017-4689-6","volume":"17","author":"X Liu","year":"2017","unstructured":"4 Liu X, Chen Y, Boucher NL, Rothberg AE (2017) Prevalence and change of central obesity among US Asian adults: NHANES 2011\u20132014. BMC Public Health 17: 678.","journal-title":"BMC Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2458","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, et al. (2007) Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr 86: 353\u2013359.","DOI":"10.1093\/ajcn\/86.2.353"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Feng WY, Li XD, Li J, Shen Y, Li Q (2021) Prevalence and risk factors of central obesity among adults with normal BMI in Shaanxi, China: a cross-sectional study. Int J Environ Res Public Health 18: 11439\u201311447.","DOI":"10.3390\/ijerph182111439"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Neeland IJ, Ross R, Despr\u00e9s JP, Matsuzawa Y, Yamashita S, et al. (2019) Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 7: 715\u2013725.","DOI":"10.1016\/S2213-8587(19)30084-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Makki K, Froguel P, Wolowczuk I (2013) Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013: 139239.","DOI":"10.1155\/2013\/139239"},{"key":"9","unstructured":"9 Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S (1983) A novel technique for the determination of body fat by computed tomography. Int J Obes 7: 437\u2013445."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 The Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity  (2002) New criteria for \u2018obesity disease\u2019 in Japan. Circ J 66: 987\u2013992.","DOI":"10.1253\/circj.66.987"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Despr\u00e9s JP, Lamarche B (1993) Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 6: 137\u2013159.","DOI":"10.1079\/NRR19930010"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12 Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome\u2014a new worldwide definition. Lancet 366: 1059\u20131062.","DOI":"10.1016\/S0140-6736(05)67402-8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, et al. (2012) Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med 44: 82\u201392.","DOI":"10.3109\/07853890.2010.526138"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, et al. (2012) Reduction of visceral fat correlates with the decrease in the number of obesity-related cardiovascular risk factors in Japanese with Abdominal Obesity (VACATION-J Study). J Atheroscler Thromb 19: 1006\u20131018.","DOI":"10.5551\/jat.12963"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, et al. (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73: 202\u2013209.","DOI":"10.1016\/j.jhep.2020.07.045"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, et al. (2002) Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25: 359\u2013364.","DOI":"10.1291\/hypres.25.359"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292: 13\u201315.","DOI":"10.1136\/bmj.292.6512.13"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55: 1318\u20131327.","DOI":"10.1016\/j.jacc.2009.10.061"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Katakami N, Osonoi T, Takahara M, Saitou M, Matsuoka TA, et al. (2014) Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients. Cardiovasc Diabetol 13: 128.","DOI":"10.1186\/s12933-014-0128-5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20 Ohkuma T, Ninomiya T, Tomiyama H, Kario K, Hoshide S, et al. (2017) Brachial-ankle pulse wave velocity and the risk prediction of cardiovascular disease: an individual participant data meta-analysis. Hypertension 69: 1045\u20131052.","DOI":"10.1161\/HYPERTENSIONAHA.117.09097"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Rodrigues SL, Baldo MP, Lani L, Nogueira L, Mill JG, et al. (2012) Body mass index is not independently associated with increased aortic stiffness in a Brazilian population. Am J Hypertens 25: 1064\u20131069.","DOI":"10.1038\/ajh.2012.91"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kim HL, Lim WH, Seo JB, Kim SH, Zo JH, et al. (2022) Association between body mass index and arterial stiffness. Cardiometab Syndr J 2: 49\u201357.","DOI":"10.51789\/cmsj.2022.2.e4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Yang F, Wang G, Wang Z, Sun M, Cao M, et al. (2014) Visceral adiposity index may be a surrogate marker for the assessment of the effects of obesity on arterial stiffness. PLoS One 9: e104365.","DOI":"10.1371\/journal.pone.0104365"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24 Zhang J, Fang L, Qiu L, Huang L, Zhu W, et al. (2017) Comparison of the ability to identify arterial stiffness between two new anthropometric indices and classical obesity indices in Chinese adults. Atherosclerosis 263: 263\u2013271.","DOI":"10.1016\/j.atherosclerosis.2017.06.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Nordstrand N, Gjevestad E, Dinh KN, Hofs\u00f8 D, R\u00f8islien J, et al. (2011) The relationship between various measures of obesity and arterial stiffness in morbidly obese patients. BMC Cardiovasc Disord 11: 7.","DOI":"10.1186\/1471-2261-11-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Choi HS, Cho YH, Lee SY, Park EJ, Kim YJ, et al. (2019) Association between new anthropometric parameters and arterial stiffness based on brachial-ankle pulse wave velocity. Diabetes Metab Syndr Obes 12: 1727\u20131733.","DOI":"10.2147\/DMSO.S211542"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kim HL, Ahn DW, Kim SH, Lee DS, Yoon SH, et al. (2021) Association between body fat parameters and arterial stiffness. Sci Rep 11: 20536.","DOI":"10.1038\/s41598-021-00175-z"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Strasser B, Arvandi M, Pasha EP, Haley AP, Stanforth P, et al. (2015) Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutr Metab Cardiovasc Dis 25: 495\u2013502.","DOI":"10.1016\/j.numecd.2015.01.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Nazare JA, Smith J, Borel AL, Aschner P, Barter P, et al. (2015) Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 115: 307\u2013315.","DOI":"10.1016\/j.amjcard.2014.10.039"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Ding Q, Zhou Y, Zhang S, Liang M (2020) Association between hemoglobin levels and non-alcoholic fatty liver disease in patients with young-onset type 2 diabetes mellitus. Endocr J 67: 1139\u20131146.","DOI":"10.1507\/endocrj.EJ20-0071"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31 Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998) Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47: 831\u2013835.","DOI":"10.1016\/S0026-0495(98)90121-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Wu Y, Zheng Q, Zou B, Yeo YH, Li X, et al. (2020) The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis. Hepatol Int 14: 259\u2013269.","DOI":"10.1007\/s12072-020-10023-3"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Tang SY, Tan JS, Pang XZ, Lee GH (2023) Metabolic dysfunction associated fatty liver disease: the new nomenclature and its impact. World J Gastroenterol 29: 549\u2013560.","DOI":"10.3748\/wjg.v29.i3.549"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Lee HW, Kim KJ, Jung KS, Chon YE, Huh JH, et al. (2017) The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter. PLoS One 12: e0187066.","DOI":"10.1371\/journal.pone.0187066"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE (1999) Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84: 137\u2013144.","DOI":"10.1210\/jc.84.1.137"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, et al. (2006) Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol 41: 462\u2013469.","DOI":"10.1007\/s00535-006-1790-5"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37 van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, et al. (2008) Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48: 449\u2013457.","DOI":"10.1002\/hep.22350"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Ampuero J, Aller R, Gallego-Dur\u00e1n R, Banales JM, Crespo J, et al. (2018) The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther 48: 1260\u20131270.","DOI":"10.1111\/apt.15015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, et al. (2020) MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40: 3018\u20133030.","DOI":"10.1111\/liv.14675"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Feng RN, Du SS, Wang C, Li YC, Liu LY, et al. (2014) Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. World J Gastroenterol 20: 17932\u201317940.","DOI":"10.3748\/wjg.v20.i47.17932"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41 Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, et al. (2007) Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care 30: 2392\u20132394.","DOI":"10.2337\/dc07-0218"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42 Okauchi Y, Kishida K, Funahashi T, Noguchi M, Morita S, et al. (2010) 4-year follow-up of cardiovascular events and changes in visceral fat accumulation after health promotion program in the Amagasaki Visceral Fat Study. Atherosclerosis 212: 698\u2013700.","DOI":"10.1016\/j.atherosclerosis.2010.06.011"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Verheggen RJ, Maessen MF, Green DJ, Hermus AR, Hopman MT, et al. (2016) A systematic review and meta-analysis on the effects of exercise training <i>versus<\/i> hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev 17: 664\u2013690.","DOI":"10.1111\/obr.12406"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Musso G, Cassader M, Paschetta E, Gambino R (2017) Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis. JAMA Intern Med 177: 633\u2013640.","DOI":"10.1001\/jamainternmed.2016.9607"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Androutsakos T, Nasiri-Ansari N, Bakasis AD, Kyrou I, Efstathopoulos E, et al. (2022) SGLT-2 inhibitors in NAFLD: expanding their role beyond diabetes and cardioprotection. Int J Mol Sci 23: 3107\u20133142.","DOI":"10.3390\/ijms23063107"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Wong C, Yaow CYL, Ng CH, Chin YH, Low YF, et al. (2020) Sodium-glucose co-transporter 2 inhibitors for non-alcoholic fatty liver disease in Asian patients with type 2 diabetes: a meta-analysis. Front Endocrinol (Lausanne) 11: 609135.","DOI":"10.3389\/fendo.2020.609135"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0554\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T03:32:11Z","timestamp":1746847931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/5\/72_EJ24-0554\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0554","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0554"}}